Biotech - Press Releases

Date	Title	Company
19-Dec-2023	Achilles Therapeutics Announces Publication of Nature Cancer ‘Comment’ on Strategy for Improved Neoantigen Immunogenicity Prediction	Achilles Therapeutics
19-Dec-2023	HERVOLUTION Therapeutics Appoints Biotech Builder J. Robert Coleman as CEO to Accelerate Groundbreaking Immunotherapies to Treat Dark Genome Targets in Cancer, Aging, and Neurodegeneration	HERVOLUTION Therapeutics
19-Dec-2023	Recipharm harmonizes its global quality operations with Veeva Vault Quality	Recipharm
18-Dec-2023	Newly developed computational tools and large datasets with low bias will lead to robust neoantigen prediction and improved personalized cancer therapies	Achilles Therapeutics plc
18-Dec-2023	Cytomos unveils patented AuraCyt™ brand and launches new website for its transformative cell analysis technology	Cytomos
18-Dec-2023	Analyzing Delivery Systems: CD Formulation Introduces In Vitro Testing to Measure Microsphere and Microneedle Release	CD Formulation
16-Dec-2023	Alfa Chemistry Leads the Way to Unleash Power of Computational Solutions in Solid State Chemistry for Pharmaceutical Research	Alfa Chemistry
15-Dec-2023	Aston University wins major funding for 3D bioprinter to enable new research into how the body works	Aston University
15-Dec-2023	ReciBioPharm partners with Acuitas Therapeutics to provide rapid technology transfers and CGMP manufacture of Acuitas’ LNP formulations	Recipharm
14-Dec-2023	Championing a Better Life: Deep Science Ventures and Parkinson’s UK Forge New Pathways in Parkinson’s Therapeutics	Deep Science Ventures
14-Dec-2023	1ST Biotherapeutics, Inc. Announces First Patient Dosed in Phase I/II Study of HPK1 Inhibitor FB849 in Patients with Advanced Solid Tumors	1ST Biotherapeutics
14-Dec-2023	Acrometa Signs Strategic Cooperation Framework Agreement to Develop Co-Working Lab Space in China	AcroMeta Group Limited
13-Dec-2023	Veranova Strengthens Leadership Further by Welcoming Lucas Sauer-Jones as Vice President & General Manager, New England	Veranova
12-Dec-2023	Pioneer Group and Innovate UK join forces on programme aiming to accelerate the development of life sciences companies	Pioneer Group
12-Dec-2023	The ACSR Democratizes Access To Pathology Data With Proscia, Advancing Breakthroughs For HIV Cancer Patients	Proscia
11-Dec-2023	ImmunOs Therapeutics Presents Details of Novel Bispecific Anti-Tumor Molecules at ESMO Immuno-Oncology Congress 2023	ImmunOs Therapeutics
08-Dec-2023	STORM Therapeutics’ First-in-Class tRNA methyltransferase inhibitor of METTL1 to be Presented at the 65th Annual ASH Conference	STORM Therapeutics
08-Dec-2023	Updated clinical safety and efficacy data for iOnctura’s roginolisib presented at ESMO Immuno-Oncology Congress 2023	iOnctura
08-Dec-2023	TILT Biotherapeutics Announces Positive Clinical Data in Checkpoint Resistant Metastatic Melanoma Phase I Trial at ESMO Immuno-Oncology 2023	TILT Biotherapeutics
08-Dec-2023	SpyBiotech Announces First Patient Dosed in Phase I Trial of SPYVLP01	SpyBiotech